Cargando…

In Vitro Modeling of the Blood–Brain Barrier for the Study of Physiological Conditions and Alzheimer’s Disease

The blood–brain barrier (BBB) is an essential structure for the maintenance of brain homeostasis. Alterations to the BBB are linked with a myriad of pathological conditions and play a significant role in the onset and evolution of neurodegenerative diseases, including Alzheimer’s disease. Thus, a de...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schreiner, Thomas Gabriel, Creangă-Murariu, Ioana, Tamba, Bogdan Ionel, Lucanu, Nicolae, Popescu, Bogdan Ovidiu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405874/ https://www.ncbi.nlm.nih.gov/pubmed/36009030 http://dx.doi.org/10.3390/biom12081136

Ejemplares similares

Should oncologists trust cannabinoids?
por: Creanga-Murariu, Ioana, et al.
Publicado: (2023)

Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer’s Disease
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)

The Blood–Brain Barrier—A Key Player in Multiple Sclerosis Disease Mechanisms
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)

The Roles of the Amyloid Beta Monomers in Physiological and Pathological Conditions
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2023)

A Nanostructured Protein Filtration Device for Possible Use in the Treatment of Alzheimer’s Disease—Concept and Feasibility after In Vivo Tests
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2023)

Impact of Caffeine on Alzheimer’s Disease Pathogenesis—Protective or Risk Factor?
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)

The “Cerebrospinal Fluid Sink Therapeutic Strategy” in Alzheimer’s Disease—From Theory to Design of Applied Systems
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2022)

The Roles of Imaging Biomarkers in the Management of Chronic Neuropathic Pain
por: Pricope, Cosmin Vasilica, et al.
Publicado: (2022)

Amyloid Beta Dynamics in Biological Fluids—Therapeutic Impact
por: Schreiner, Thomas Gabriel, et al.
Publicado: (2021)

Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer’s Disease in Relation to Therapeutic Editing Tools
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2022)

Osteonecrosis of the Femoral Head in Patients with Hypercoagulability—From Pathophysiology to Therapeutic Implications
por: Rezus, Elena, et al.
Publicado: (2021)

Observation of Intact and Proteolytically Cleaved Amyloid-Beta (1–40)-Oleuropein Noncovalent Complex at Neutral pH by Mass Spectrometry
por: Caba, Ioana Cezara, et al.
Publicado: (2021)

Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer’s Disease and Diabetes
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2021)

Contributions of Mass Spectrometry to the Identification of Low Molecular Weight Molecules Able to Reduce the Toxicity of Amyloid-β Peptide to Cell Cultures and Transgenic Mouse Models of Alzheimer’s Disease
por: Ştefănescu, Raluca, et al.
Publicado: (2019)

The Therapeutic Potential of the Endocannabinoid System in Age-Related Diseases
por: Tudorancea, Ivona Maria, et al.
Publicado: (2022)

Age‐related ultrastructural changes of the basement membrane in the mouse blood‐brain barrier
por: Ceafalan, Laura Cristina, et al.
Publicado: (2018)

Dysautonomia in Alzheimer's Disease
por: Tulbă, Delia, et al.
Publicado: (2020)

Intrathecal Pseudodelivery of Drugs in the Therapy of Neurodegenerative Diseases: Rationale, Basis and Potential Applications
por: Manuel, Menéndez-González, et al.
Publicado: (2023)

Secondary Metabolites from Plants Possessing Inhibitory Properties against Beta-Amyloid Aggregation as Revealed by Thioflavin-T Assay and Correlations with Investigations on Transgenic Mouse Models of Alzheimer’s Disease
por: Stefanescu, Raluca, et al.
Publicado: (2020)

Triggers and Effectors of Oxidative Stress at Blood-Brain Barrier Level: Relevance for Brain Ageing and Neurodegeneration
por: Enciu, Ana-Maria, et al.
Publicado: (2013)

Altered expression of claudin family proteins in Alzheimer’s disease and vascular dementia brains
por: Romanitan, Mihaela O, et al.
Publicado: (2010)

Renal Contributions in the Pathophysiology and Neuropathological Substrates Shared by Chronic Kidney Disease and Alzheimer’s Disease
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2020)

Occludin is overexpressed in Alzheimer's disease and vascular dementia
por: Romanitan, Mihaela Oana, et al.
Publicado: (2007)

Remote Ischemic Conditioning in Acute Ischemic Stroke – A Clinical Trial Design
por: Poalelungi, Alina, et al.
Publicado: (2020)

An Immunoenzymatic Method for the Determination of Ochratoxin A in Biological Liquids (Colostrum and Cow’s Milk)
por: Cuciureanu, Magdalena, et al.
Publicado: (2021)

Nanomaterials Designed for Antiviral Drug Delivery Transport across Biological Barriers
por: Cojocaru, Florina-Daniela, et al.
Publicado: (2020)

Still debating a cause and diagnostic criteria for Alzheimer's disease
por: Popescu, Bogdan O
Publicado: (2007)

Temporomandibular Joint Osteoarthritis: Pathogenic Mechanisms Involving the Cartilage and Subchondral Bone, and Potential Therapeutic Strategies for Joint Regeneration
por: Cardoneanu, Anca, et al.
Publicado: (2022)

Connections between Orthopedic Conditions and Oxidative Stress: Current Perspective and the Possible Relevance of Other Factors, Such as Metabolic Implications, Antibiotic Resistance, and COVID-19
por: Huzum, Bogdan, et al.
Publicado: (2022)

Remote Ischemic Conditioning May Improve Disability and Cognition After Acute Ischemic Stroke: A Pilot Randomized Clinical Trial
por: Poalelungi, Alina, et al.
Publicado: (2021)

Preclinical Studies of Canagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor, and Donepezil Combined Therapy in Alzheimer’s Disease
por: Stanciu, Gabriela Dumitrita, et al.
Publicado: (2023)

SURVIVAL OF NONAGENARIAN PATIENTS WITH HIP FRACTURES: A COHORT STUDY
por: Ovidiu, Alexa, et al.
Publicado: (2017)

Sulfiredoxin-1 blood mRNA expression levels negatively correlate with hippocampal atrophy and cognitive decline
por: Cucos, Catalina Anca, et al.
Publicado: (2022)

The blood-brain barrier in Alzheimer's disease
por: Zenaro, Elena, et al.
Publicado: (2017)

Blood Pressure Patterns in Patients with Parkinson’s Disease: A Systematic Review
por: Tulbă, Delia, et al.
Publicado: (2021)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

From Pathogenesis to Therapy in Knee Osteoarthritis: Bench-to-Bedside
por: Rezuş, Elena, et al.
Publicado: (2021)

Blood–Brain Barrier Dysfunction in a 3D In Vitro Model of Alzheimer's Disease
por: Shin, Yoojin, et al.
Publicado: (2019)

Blood–brain-barriers in aging and in Alzheimer’s disease
por: Marques, Fernanda, et al.
Publicado: (2013)

Surgical technique of concomitant laparoscopically assisted vaginal hysterectomy and laparoscopic cholecystectomy
por: STANCU, BOGDAN, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7h6paqf06atje8dp03a4muk4ee